Please login to the form below

Not currently logged in
Email:
Password:

Abraxane

This page shows the latest Abraxane news and features for those working in and with pharma, biotech and healthcare.

Celgene joins PD-1 race via partnership with BeiGene

Celgene joins PD-1 race via partnership with BeiGene

BeiGene is also acquiring Celgene's commercial operations in Asia with the right to sell blood cancer therapies Revlimid (lenalidomide) and Vidaza (azacitidine) and Abraxane (albumin-bound paclitaxel) for pancreatic cancer -

Latest news

More from news
Approximately 15 fully matching, plus 28 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    cells. A good example of this is the combined use of  Abraxane and  gemcitabine in the treatment of  metastatic adenocarcinoma of the pancreas – Abraxane helps to inhibit cancer cell growth, and

  • Serviceplan Health & Life

    Our network has helped launch or is launching these brands across multiple markets: Abraxane, Cimzia, Eliquis, Elotuzumab, Extavia, Gilenya, Intelence, Lonsurf, Lonquex, Spiriva, Toctino, Votrient, VX-809, and Xeomin.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

What the smartest pharma marketers know about digital
To understand what separates the top digital pharma marketers from the rest, here are five things that they know – and enact daily in their communications planning & execution....
Digital Pharma Advances 2018: Attend our presentation in London
We are very excited to be attending and speaking at The Digital Pharma Advances Conference, held January 30th in London....
healthcare data technology
Integrating digital biomarkers into precision medicine
Leveraging digital technologies to enhance the clinical evaluation and delivery of precision therapies...

Infographics